A recent study has demonstrated that CYP39A1, a liver-specific autosomal gene that has a female-preferential expression, strongly suppressed HCC development and resulted in a dramatic downregulation in over 90% of HCC patients [93]. This evidence concerns the gene CYP39A1 and hepatocellular carcinoma.